A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.

Why are some filings missing?

New filings appear as the SEC updates EDGAR, and older records can vary by availability.

How often is this page updated?

Updates follow new EDGAR submissions and periodic data refreshes.

SEC EDGAR filings, ownership reports, and insider transactions for Norman D. LaFrance.

Business address: Molecular Insight Pharmceuticals, Inc., 160 Second Street, Cambridge, MA, 02142

Get insider transactions for this reporting owner

Norman D. LaFrance has filed 14 SEC EDGAR filings since 26 Apr 2007

Recent SEC filings for Norman D. LaFrance including 4, 4/A, 3.

Form type	Document	Filing	Description	Filing date	Reporting date	File number(s)
4	Open 4 document	View SEC filing for 4	4	26 Feb 2024	22 Feb 2024	001-34375
4	Open 4 document	View SEC filing for 4	FORM 4 SUBMISSION	17 Feb 2023	15 Feb 2023	001-34375
4/A	Open 4/A document	View SEC filing for 4/A	FORM 4/A SUBMISSION	28 Mar 2022	11 Nov 2021	001-34375
4	Open 4 document	View SEC filing for 4	FORM 4 SUBMISSION	24 Nov 2021	11 Nov 2021	001-34375
3	Open 3 document	View SEC filing for 3	FORM 3 SUBMISSION	24 Nov 2021	11 Nov 2021	001-34375

Norman D. LaFrance files with the SEC under CIK 0001397768. This page aggregates EDGAR filings and related ownership activity.

What is a CIK?: A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?: New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?: Updates follow new EDGAR submissions and periodic data refreshes.